In HCC, TGF-β-induced METTL3-mediated m6A modification destabilizes ITIH1 mRNA, disrupting fibronectin and focal adhesion kinase signaling, thus driving tumor growth and invasion (66). Here, METTL3 is linked to neoplasm.